EKSPLA UAB

Their core work

EKSPLA is a Lithuanian laser manufacturer that develops and produces pulsed and ultrafast laser systems used across scientific and industrial applications. In H2020 projects, they contribute specialized laser sources and photonic components — for bio-photonic imaging (FBI), photoacoustic medical diagnostics (PAMMOTH), and micro-LED/OLED direct patterning (MiLEDI). Their role is consistently that of a laser technology supplier enabling partners to build advanced optical instruments and manufacturing processes.

What they specialise in

How they've shifted over time

EKSPLA's H2020 involvement spans 2016–2018 start dates, all within a narrow window, so evolution is subtle rather than dramatic. Their earlier projects (FBI, PAMMOTH) applied laser systems to biomedical imaging — functional bio-photonics and photoacoustic mammography. The most recent project (MiLEDI, 2018) pivots toward industrial manufacturing, specifically laser patterning for micro-LED and OLED displays, signaling a shift from life science instrumentation toward advanced manufacturing applications.

EKSPLA appears to be expanding from scientific instrumentation into industrial laser processing for next-generation display technologies, making them relevant for advanced manufacturing consortia.

How they like to work

EKSPLA participates exclusively as a partner, never as coordinator — consistent with their role as a specialist technology supplier contributing laser hardware to larger research efforts. With 30 unique partners across 10 countries from just 3 projects, they integrate well into mid-to-large European consortia. Their value proposition is clear and modular: they provide the laser system, others build the application around it.

EKSPLA has built connections with 30 distinct consortium partners across 10 European countries through just 3 projects, indicating broad geographic reach relative to their project count. Their network spans both academic research groups and medical/industrial end-users.

What sets them apart

EKSPLA is one of few SMEs in the EU that both manufactures commercial laser systems and participates in R&D consortia, meaning they can move results from the lab bench to a product catalog. Their dual presence in biomedical imaging and display manufacturing gives them unusual cross-sector versatility. For consortium builders, they offer a reliable, commercially grounded laser partner rather than a purely academic contributor.

Highlights from their portfolio

• PAMMOTH
  Largest single grant (EUR 410,469) — developing photoacoustic/ultrasound mammography, combining laser technology with a direct clinical diagnostic application.
• MiLEDI
  Represents EKSPLA's strategic move into display manufacturing, applying laser and electron beam patterning to quantum dot micro-LEDs and OLEDs.